As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...

The key player in SARS-CoV-2's infection process is the receptor binding domain (RBD) of the spike protein. The RBD determines how well the virus binds to ACE2, the human cellular receptor ...

CoV-2, a new merbecovirus found in bats across China, that utilises the ACE2 receptor for cellular entry—raising concerns ...

This pairing of antibodies was shown to be effective against the initial SARS-CoV-2 virus that caused the ... to get a foothold and attach to the receptor-binding domain, or RBD, of the virus ...

The new virus, too, was discovered in the bats first..New coronavirus variant , China New Coronavirus , HKU5 COV-2 ...

This pairing of antibodies was shown to be effective against the initial SARS-CoV-2 virus that caused the ... to get a foothold and attach to the receptor-binding domain (RBD) of the virus ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could ...

This pairing of antibodies was shown to be effective against the initial SARS-CoV-2 virus that caused the ... to get a foothold and attach to the receptor-binding domain, or RBD, of the virus ...